Does Pennsylvania Medicaid Cover Wegovy or Zepbound?
Pennsylvania (PA) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Pennsylvania Medicaid cover weight-loss GLP-1s, has Pennsylvaniaexpanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Pennsylvania GLP-1 access landscape
Pennsylvania Medicaid ended weight-loss GLP-1 coverage for adults 21+ effective January 1, 2026 (fee-for-service and managed care alike), projected to save ~$380 million through the following fiscal year after 2024 spend hit $650 million; Saxenda lost coverage for ALL indications. Coverage continues for other medically accepted indications (e.g. type 2 diabetes) and for beneficiaries under 21. UPMC Health Plan is integrated with UPMC hospitals. Source: phlp.org, spotlightpa.org (2025-12), pa.gov MA Bulletin 2025-11-24.
Top insurers in Pennsylvania: Highmark Blue Cross Blue Shield, Independence Blue Cross, UPMC Health Plan.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only a handful of states (Pennsylvania not among them) currently do.
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's state health plan dropped Wegovy and Zepbound coverage in 2024 specifically over cost - a widely cited case study in employer pushback that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Pennsylvania-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Pennsylvania residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Frequently asked questions
Does Pennsylvania Medicaid cover Wegovy or Zepbound for weight loss?
No - Pennsylvania Medicaid does not cover GLP-1 medications specifically for weight loss as of 2026. Coverage for type 2 diabetes indications (Ozempic, Mounjaro) may still apply if you have that diagnosis. Federal law also excludes weight-loss drugs from Medicare Part D regardless of state, so this is a state Medicaid policy question, not a federal one.
Has Pennsylvania expanded Medicaid under the ACA?
Yes - Pennsylvania has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the Pennsylvania state employee health plan cover Wegovy or Zepbound?
Yes - Pennsylvania's state employee health plan covers weight-loss GLP-1s, typically with prior authorization. State employee plans are often a useful leading indicator of where commercial insurers in the state are heading, since large state plans negotiate directly with PBMs and set precedent other employers watch.